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Abstract
Background: Recently, we identified cysteine-rich with EGF-like domains 2 (CRELD2) as a novel endoplasmic
reticulum (ER) stress-inducible gene and characterized its transcriptional regulation by ATF6 under ER stress
conditions. Interestingly, the CRELD2 and asparagine-linked glycosylation 12 homolog (ALG12) genes are arranged as
a bidirectional (head-to-head) gene pair and are separated by less than 400 bp. In this study, we characterized the
transcriptional regulation of the mouse CRELD2 and ALG12 genes that is mediated by a common bidirectional
promoter.
Results: This short intergenic region contains an ER stress response element (ERSE) sequence and is well
conserved among the human, rat and mouse genomes. Microarray analysis revealed that CRELD2 and ALG12
mRNAs were induced in Neuro2a cells by treatment with thapsigargin (Tg), an ER stress inducer, in a time-
dependent manner. Other ER stress inducers, tunicamycin and brefeldin A, also increased the expression of these
two mRNAs in Neuro2a cells. We then tested for the possible involvement of the ERSE motif and other regulatory
sites of the intergenic region in the transcriptional regulation of the mouse CRELD2 and ALG12 genes by using
variants of the bidirectional reporter construct. With regards to the promoter activities of the CRELD2-ALG12 gene
pair, the entire intergenic region hardly responded to Tg, whereas the CRELD2 promoter constructs of the proximal
region containing the ERSE motif showed a marked responsiveness to Tg. The same ERSE motif of ALG12 gene in
the opposite direction was less responsive to Tg. The direction and the distance of this motif from each
transcriptional start site, however, has no impact on the responsiveness of either gene to Tg treatment.
Additionally, we found three putative sequences in the intergenic region that antagonize the ERSE-mediated
transcriptional activation.
Conclusions: These results show that the mouse CRELD2 and ALG12 genes are arranged as a unique bidirectional
gene pair and that they may be regulated by the combined interactions between ATF6 and multiple other
transcriptional factors. Our studies provide new insights into the complex transcriptional regulation of bidirectional
gene pairs under pathophysiological conditions.
Background
Among eukaryotes, analyses of the human and mouse
genomes revealed that more than 10% of the genes are
arranged as bidirectional gene pairs that are separated
by less than only 1 kb of genomic DNA [1-3]. Some of
these gene pairs could have evolved from a common
ancestral gene during its duplication. Other gene pairs,
however, do not have any genetic relationship between
each other, and they are thought to play different biolo-
gical functions within cells. It has been reported that the
human PACPG-PARK2 gene pair [4], the human
PREPL-C2ORF34 gene pair [5], the mouse surfeit Surf1-
Surf2 gene pair [6] and the mouse Sars2-Mrps12 gene
pair [7] are co-regulated by distinctive transcriptional
f a c t o r ss u c ha sN R F - 2 ,Y Y - 1o rN F - Y .T h et r a n s c r i p -
tional regulation of many other eukaryotic bidirectional
gene pairs, however, remains to be determined.
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i n d u c i b l eg e n eb yam i c r o a r r a ya n a l y s i so fT g - s e n s i t i v e
genes in Neuro2a cells and characterized the 5’-
upstream promoter region of the mouse CRELD2 gene
[8]. Some pathophysiological conditions are reported to
disrupt ER functions (e.g., the folding and modifying of
newly synthesized transmembrane and secretory pro-
teins) due to an accumulation of unfolded proteins
[9,10]. The accumulation of unfolded proteins activates
the expression of various genes through three resident
ER stress sensors, PERK [11], IRE [12] and ATF6 [13].
The activation of these genes results in various out-
comes (e.g., the refolding and/or degradation of accu-
mulated proteins in the ER, and the activation of
apoptotic signaling cascades). One of these ER stress
sensors, ATF6, directly regulates the transcription of the
CRELD2 gene via the ERSE motif, an ATF6 consensus
sequence, located in its promoter [8]. The nucleotide
sequence around the ERSE in the CRELD2 promoter is
highly conserved within the mouse, rat and human
genes. Interestingly, further genomic analyses reveal that
the ALG12 gene, one of the mannosyltransferase genes
[14], is adjacent to the CRELD2 gene in a head-to-head
configuration on the chromosome in some species. In
this study, we first investigated the transcriptional regu-
lation of the bidirectional CRELD2-ALG12 gene pair as
ER stress-inducible genes. We especially focused on
evaluating the role of the ERSE motif, which is located
within the 360-bp intergenic region, in regulating the
expression of both genes under ER-stress conditions.
Results
ER stress induced the expression of both CRELD2 and
ALG12 mRNAs in Neuro2a cells
Microarray analyses revealed that both CRELD2 and
ALG12 mRNAs are induced in Tg-treated cells as well
as GADD153 [15], Tib3 [16] and Herpud1 [17] mRNA,
which are known ER stress-inducible genes (Table 1).
To verify the Tg-induced expression of CRELD2 and
ALG12 mRNAs in detail, Neuro2a cells were exposed to
0.1 μM Tg for 4, 8, or 12 h, and the expression of
CRELD2, ALG12, GRP78 and GADD153 mRNAs were
measured by RT-PCR. As shown in Figure 1A, CRELD2
and ALG12 mRNAs, as well as GRP78 [18] and
GADD153 mRNAs, were up-regulated from 4 to 12 h
after Tg-treatment. Next we examined the effects of
other ER stress-inducing reagents (Tm and BFA), as
well as serum withdrawal, on CRELD2 and ALG12
mRNA expression in Neuro2a cells. Like Tg treatment,
those with Tm and BFA, but not serum withdrawal,
induced CRELD2, ALG12, GRP78 and GADD153 mRNA
expression similarly (Figure 1B).
Comparison of the intergenic sequences of the CRELD2-
ALG12 gene pair within the mouse, rat and human genes
Next we analyzed the intergenic sequences of the CRELD2-
ALG12 gene pair within the mouse, rat and human genes.
As shown in Figure 2, the nucleotide sequence of the
mouse gene pair is highly homologous to that of the rat
gene pair. The proximal promoter regions of the human
and mouse CRELD2 genes, especially around the ERSE
motif, are also well conserved. We then measured the basal
promoter activities of the mouse CRELD2-ALG12 gene
pair by using luciferase reporter constructs inserted with
e i t h e rt h ee n t i r ei n t e r g e n i cr e g i o n( - 3 9 6~+ 1 1 )o rt h e
intergenic region containing various deletion mutations in
either direction. As shown in Figure 3A, reporter con-
structs containing the entire intergenic region in either
direction (+11/-396; CRELD2 promoter and -396/+11;
ALG12 promoter) showed the higher basal promoter activ-
ity. The activity of ALG12 promoter (-211/+11) is still high
in the absence of the ERSE motif, however a further dele-
tion from position -211 to -108 in this promoter remark-
ably decreased its basal activity in Neuro2a cells.
Furthermore, a deletion from position -136 to -228 in the
CRELD2 promoter dramatically decreased CRELD2 pro-
moter activity even though the ERSE motif is present. The
deletion of a region around the ERSE motif (-229 ~ -254)
further decreased the promoter activity.
The role of the ERSE motif in CRELD2 and ALG12
promoter activities under ER stress condition
A ss h o w ni nF i g u r e3 B ,t h em o u s eCRELD2 promoter
containing the proximal region (-229 ~ -396), but no
Table 1 Tg-inducible genes in Neuro2a cells
Genes Name RefSeq No. Fold induction
4h 8h
ddit3 (GADD153) DNA-damage inducible transcript 3 NM_007837 6.1 9.8
trib3 tribbles homolog 3 NM_175093 3.9 7.2
herpud1 homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 NM_022331 4.4 6.0
creld2 cysteine-rich with EGF-like domains 2 NM_029720 2.9 4.3
alg12 asparagine-linked glycosylation 12 homolog NM_145477 3.6 3.7
Neuro2a cells were treated with or without 0.1 μM Tg for 4 or 8 h. Total RNA was isolated from each cells and subjected to identify Tg-inducible genes using
microarray analysis as described in methods. Representative genes are shown as ratio (Tg-treated cells/control cells).
Oh-hashi et al. BMC Genomics 2010, 11:664
http://www.biomedcentral.com/1471-2164/11/664
Page 2 of 13deletion mutation construct of mouse ALG12 promoter,
was significantly activated by Tg-treatment. Consistent
with our previous report, the CRELD2 promoter con-
struct containing the longer intergenic region (-136 ~
-396) showed higher basal promoter activity but a lower
responsiveness to Tg compared to the above-mentioned
construct (-229/-396) (Figure 3B). The CRELD2 promo-
ter without the ERSE motif (-255/-396) had an even
further diminished basal promoter activity and Tg-
responsiveness. Next, we determined the effect of var-
ious mutations within the ERSE motif on the activity of
the mouse ALG12 promoter. Unlike the CRELD2 pro-
moter (-229/-396) and its point mutation constructs
(-229/-396 m1 or m2; a mutation at the ATF6 or NF-Y
binding site [8,13,18-20], respectively), the mutations in
the ALG12 promoter (-361/+11 m1 and m2) did not
affect the basal promoter activity and the responsiveness
to Tg (Figure 4). Then, we evaluated the effect of the
ERSE motif’s direction on the responsiveness of the
mouse CRELD2-ALG12 gene pair to Tg by using a
pGL3 vector containing the SV40-promoter. The repor-
ter constructs containing a partial intergenic region of
the gene pair (-343 ~ -212) in either direction
responded to Tg and ATF6-overexpression similarly
(Figure 5A and 5B). Interestingly, Tg-treatment and
ATF6-overexpression stimulated the luciferase activity
of the CRELD2 promoter (-229/-396) construct more
effectively than the ALG12 promoter (-361/+11) con-
struct (Figure 5C and 5D).
To study the unresponsiveness of the ALG12 promo-
ter (-361/+11) to Tg, we prepared another reporter con-
struct in which the middle intergenic region of the
ALG12 promoter (-211 ~ -108) that contributes to the
basal promoter activity is deleted (Figure 3A). This con-
struct (-343/-212 & -107/+11), however, did not respond
to Tg (Figure 6A). Serial deletions of the 3’-end of the
ALG12 promoter lacking the middle intergenic region
revealed that there is a suppressive site from position
-75 to -16 in the ALG12 promoter (Figure 6B). Deletion
around three putative Ets family binding sites (TTCC)
[21,22] from position -52 to -2 0( F i g u r e2 ,s i t eI I I )i n
the ALG12 promoter (-343/-212 & -107/+11 m1) also
restored responsiveness to Tg. Yet, this same site III
deletion in the ALG12 promoter containing the middle
intergenic region (-361/+11 m3) showed unresponsive-
ness to Tg (Figure 6C). To determine if there are other
suppressive sites in this intergenic region, we prepared
various deletion mutation constructs of the ALG12 pro-
moter and evaluated their responsiveness to Tg. As
shown in Figure 7A, we identified two additional sup-
pressive sites (I and II in Figure 2). We also found that
the deletion of all three sites (-361/+11 m7; ALG12 pro-
moter) was required in order to restore the responsive-
ness to Tg. A mutation in either the NF-Y binding site
(CCAAT) of the ERSE motif (-361/+11 m8) or a site
8-bp downstream of the ERSE motif (-361/+11 m9) in
the ALG12 promoter showed that each NF-Y binding
site partially participated in its basal promoter activity.
B
Con Tg Tm BFA SF Time (h) 0 4 8 12
A
CRELD2 CRELD2
ALG12 ALG12
GRP78 GRP78
GADD153 GADD153
GAPDH GAPDH
Figure 1 ER stresses induced CRELD2 and ALG12 mRNA in Neuro2a cells. A) Neuro2a cells were treated with 0.1 μMT gf o rt h ei n d i c a t e d
time. B) Neuro2a cells were treated with Tg (0.1 μM), Tm (5 μg/ml), BFA (5 μg/ml), serum-free (SF) or vehicle for 6 h. Total RNA isolated from
each sample was subjected to RT-PCR as described in methods.
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(-361/+11 m8), however, are crucial to the responsive-
ness to Tg as well as the CRELD2 promoter (-209/+396
m1) (Figure 7B and 7C). Finally, we measured the pro-
moter activity of the entire intergenic region of the
CRELD2-ALG12 gene pair in the both direction (-396/
+11; CRELD2 and ALG12 promoters) after Tg treatment
or ATF6 cotransfection. Both promoter constructs only
slightly responded to Tg, but the deletion of the three
suppressive regions (+11/-396 m1; CRELD2 promoter
and -396/+11 m1; ALG12 promoter) restored respon-
siveness to Tg. Furthermore, the basal promoter activ-
ities of these mutant constructs markedly decreased
(Figure 8A). ATF6-overexpression enhanced the promo-
ter activity of all of the above-mentioned constructs.
The Tg-responsive reporter constructs (+11/-396 m1
and -209/-396; CRELD2 promoters and -396/+11 m1;
ALG12 promoter) also showed a further increase
in their promoter activities by ATF6-overexpression
(Figure 8B).
ACTGCGGCGGAGTCTGAGCCTCCGCCCACCGGCCCG-CGCGCCGGCC-GTTCCCCGGGCTAC
ACTGCGGCGGAGTCTGAGCCTCCGCCCACCGGCCCG-CGCGCCGGCC-GTTCCCCGGGCTAC
GCTGCTCCGGCCTCCCGGCCGCCCACCCGCTCCCAGCCGCGCCGGCCTGTCCCCCAGGCTAC
****  *** **  *** **  ** * ** * ********** ** **** ******
TTGACTGCGTCGCCGAGGCCCCG-CCCACCTTTCACCCCGCGCGCTTCTATTGGCCGGAGGA
TTGACTGCAACGCCGAGGCCCCG-CCCACCTTTCACACTGCGCGTTTCTATTGGTCGGAGGA
TTGACGGCGCCGGCGAGGCCCCGCCCCACCCGCCAGCCC-CGCGCCGCTATTGGTTGATGGG
***** ** ** ********** ******   ** * ***    *******  *  **
ATCC-CCCTTGCCTGATGTGGACCAATTGAGGCTCGCCACGAGAAGCCACCAATGAGAAGGC
ATCC-CCCCTGCCTGATGTGGACCAATTGAGGCTCGCCACGAGAAGCCACCAATGAGAAAGC
ACCCGCCCCGGCCTGATATGGCCCAATCCGAGTTCGCCACGAGAGGTGACCAATGGGAAGGC
* ** ***  ******* *** *****    * *********** *   ******* *** **
CCCGGGTCAGCGTCC--CGCGAGAATGAGGCAGAACCGT---------AATCTTCTATCGGG
CCCGGGTCAGCGTCC--CGCGAGAATGAGGCGGAACCGT---------AA---TCTATCCGG
CCCGGATCAGCGGCCGCCAGGAGTCCGGGGGCGGGGCGTGCAGGTCCGACCCCGCCTCCCGC
***** ****** **  * *** * ** *   ***        * ޓޓ * ޓޓ**
TCCCCATGCCCCGCCCTC--CACG-AGT----------GGCCATCTTTTCTCCGGGCGGGAA
TCTTCTTGCCCCGCCCTC--CACG-AGTGGCCTGCGGCGGCCATCTTTTCTCCGGGCGGGAA
TCCCCGCCCCTCGCGCGCAGCCCGCGGC----------GGCCATCTTTACTCAGGGCACAGA
**  * ** *** * * ** * ********** *** **** *
GCGCCAGCTGCGGTCG--CCAGCCTGGGCAATGGTGGCCATGTCAAGTTCGGGCAAAGACTT
GTGCCCGCCTCTGTGG--CCAGCTTGAGCAATGGTGGCCATGTTAAGTTCGGGCAAAGATTT
GGGTC-TCTGCGGCCGTAGCGGCCGGGGCTGCGGTAGCCACTTTAGATTTGGGCAAGGACTT
*** ** ޓ* ޓ ** * ޓ* ** *** ****  * * ** ****** ** **
GGCTTCCGGGCCCGGT-----TTCCGCAG-CCGGCTTCCTGCCTTGGTCAGTCTGCTCAGTT
GGCTTCTTGGCCTGGC-----TTCCGCGG-CCGGCTTCCTGCGGAAGGTAGTCTTGTGAGTT
TAGATTCGGGCTCTGTTCTGTTTCCGCCGTCCTGCTTCCTGCCGAGGCTGGCCCAGGCAGCC
* *** * ****** * ** ********* * * * **
CCGCGGGGT
CCGAGGGGC
GCGCTTCGA
** *
Mouse
Rat
Human
+1
-396
CRELD2
(I)
(II)
(III)
-362
ALG12
+11
Figure 2 Nucleotide sequences of the mouse, rat and human CRELD2-ALG12 gene pairs. Nucleotide sequences conserved among the
mouse, rat and human CRELD2-ALG12 gene pairs are shown with asterisks. A conserved ERSE motif and an adjacent NF-Y binding site are shown
in a box and underline, respectively. The transcriptional direction and putative transcriptional start sites of the mouse CRELD2 and ALG12 genes
are shown with arrows and arrowheads, respectively. Three suppressive regions identified in this study are shown with broken lines (sites I, II and
III). Putative binding sequences of the Ets family (TTCC) in site III are shown with bold types.
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Recently, we identified CRELD2 as a novel ER-stress
inducible gene and characterized its ATF6-dependent
transcriptional regulation using constructs containing the
proximal region of the mouse CRELD2 promoter [8].
Genomic analyses reveal that the ALG12 gene [14] is
adjacent to the CRELD2 gene in a head-to-head config-
uration on the chromosome in some species. CRELD2
and ALG12 genes are a bidirectional gene pair arranged
less than 400 bp apart. The nucleotide sequences of this
intergenic region are moderately conserved among the
mouse, rat and human genes. Furthermore, those regions
around an ERSE motif in the CRELD2-ALG12 gene pair
are highly conserved (Figure 2). In this study, we demon-
strate that the expression of CRELD2 and ALG12
mRNAs, and GRP78 and GADD153 mRNAs, which are
well known ER stress-inducible genes, was induced by
three distinct ER stress inducers (Figure 1). In regards to
the promoter activity of the mouse CRELD2-ALG12 gene
pair, only the CRELD2 promoter containing just the
proximal region (-229/-396 and -209/-396; CRELD2 pro-
moter) significantly responded to Tg. Additionally, the
CRELD2 promoter containing the full intergenic region
(+11/-396; CRELD2 promoter) decreased in responsive-
ness to Tg, whereas its basal promoter activity markedly
increased. In contrast, the ALG12 promoters only slightly
responded to Tg even though some of the reporters con-
tained the ERSE motif, which is 300-bp apart from the
transcription start site of the mouse ALG12 gene. The
direction of the ERSE motif and its distance from each of
the transcription start sites for the mouse CRELD2 or
ALG12 genes, however, appear to have no influence in
these findings. Therefore, it seems that the full intergenic
region contains one or more unknown suppressive sites
that interfere with the ERSE-mediating enhancement of
the ALG12 and CRELD2 promoter activities.
0 50 100 150 200 250
pGL3b -
+
Tg
-
+ -255/-396
-
+ -211/+11
-
+ -229/-396
Relative luciferase activity
CRELD2
ALG12
-
+ -361/+11
-
+ -136/-396
B
pGL3b
0 20 40 60 80 100 05 0 1 0 0 1 5 0 2 0 0
-211/+11
-107/+11
-255/-396
-361/+11
-136/-396
-229/-396
Relative luciferase activity Relative luciferase activity
-396/+11 +11/-396
ALG12 CRELD2
A
Figure 3 Promoter activity of the mouse CRELD2-ALG12 gene pair in Neuro2a cells. Neuro2a cells were transfected with various luciferase
reporter constructs containing successive 5’-deletion mutations of the mouse CRELD2 and ALG12 promoter sequences. A) Thirty-six hours after
transfection, luciferase activity was measured. B) Twenty-four hours after transfection, the cells were incubated with or without Tg (0.1 μM) for 10
h, and luciferase activity was measured. The promoter activity in the absence (-) or presence (+) of Tg is shown as open and closed columns,
respectively. Values represent means ± SD from 3 independent cultures and are expressed relative to the basal activity of the pGL3-Basic vector.
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Page 5 of 13Reporter constructs used in this study contain 5’-
untranslated regions (5’-UTR) of CRELD2 and/or
ALG12 gene. Especially, reporter constructs containing
the entire intergenic region of CRELD2 - ALG12 gene
pair contain the UTR regions at both ends. However,
the deletion of three suppressive sites (sites I, II and III)
in each construct recovered the responsiveness to Tg
(-343/-212 - -107/+11 m1 in Figure 6C and -361/+11
m7, +11/-396 m1 and -396/+11 m1 in Figure 7A and
8A). Therefore, it seems likely that each 5’-UTR hardly
ERSE consensus
CCAAT---N9----CCACG
GGTTA---N9----GGTGC
mCRELD2-ALG12 ERSE CCAATTGAGGCTCGCCACG -254 -236
mCRELD2-ALG12 ERSE m1 CCAATTGAGGCTCGgatgt
mCRELD2-ALG12 ERSE m2 gactaTGAGGCTCGCCACG
A
0 50 100 150 200 250
pGL3b -
+
Tg
-
+ -361/+11
-
+ -361+11 m1
-
+ -361/+11m2
ALG12
Relative luciferase activity
ERSE
B
0 1 02 03 04 0
pGL3b -
+
Tg
-
+ -229/-396
-
+ -229/-396 m1
-
+ -229/-396 m2
Relative luciferase activity
CRELD2
C
Figure 4 Role of the ERSE motif in mouse CRELD2 and ALG12 promoter activities in Neuro2a cells. A) The nucleotide sequence of a
common ERSE motif in the mouse CRELD2-ALG12 gene is shown. NF-Y and ATF6 binding sequences in the ERSE motif and their mutated
sequences are shown with bold types and small letters, respectively. Neuro2a cells were transfected with the indicated CRELD2 or ALG12 reporter
constructs. Twenty-four hours after transfection, the cells were incubated with or without Tg (0.1 μM) for 10 h (B and C). After incubation, the
cells were lysed and luciferase activity was measured as described in methods. The activities obtained from control and Tg-treated cells are
shown as open and closed columns, respectively. Values represent means ± SD from 3 - 4 independent cultures and are expressed relative to
the basal activity of the pGL3-Basic.
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Relative luciferase activity
Tg
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+
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CRELD2
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D
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-
+
ATF6
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-
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ALG12
-
+ -229/-396
-361/+11
Figure 5 Role of nucleotide sequence around the ERSE motif in mouse CRELD2 and ALG12 promoters in regulating the transcriptional
activity of both genes. Neuro2a cells were transfected with the indicated CRELD2 or ALG12 reporter constructs. Twenty-four hours after
transfection, the cells were incubated with or without Tg (0.1 μM) for 10 h (A and C). The expression vector for ATF6 or an empty vector (mock)
was co-transfected with each reporter construct into Neuro2a cells and cultured for 36 h (B and D). After incubation, the cells were lysed and
luciferase activity was measured as described in methods. Control and Tg-treated or ATF6-stimulated activities are shown as open and closed
columns, respectively. Values represent means ± SD from 3 - 4 independent cultures and are expressed relative to the basal activity of the pGL3-
Promoter (A and B) and pGL3-Basic (C and D).
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-
+
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Figure 6 Role of the proximal region of the mouse ALG12 promoter in regulating the transcriptional activity of the gene. Neuro2a cells
were transfected with the indicated CRELD2 or ALG12 reporter constructs. Twenty-four hours after transfection, the cells were incubated with or
without Tg (0.1 μM) for 10 h, and luciferase activity was measured. A deleted site in the most proximal region of the ALG12 promoter is shown
as site III. Control and Tg-treated activities are shown as open and closed columns, respectively. Values represent means ± SD from 3
independent cultures and are expressed relative to the basal activity of the pGL3-Basic vector (A, B and C).
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Page 8 of 13influenced the corresponding promoter activity of the
CRELD2 and ALG12 promoter constructs in our assay
system. CRELD2 (NM_029720.2) and ALG12
(NM_145477.1) genes possess 5’-UTR (66 and 55 bp)
and 3’-UTR (245 and 584 bp) respectively though their
effects on transcription are not elucidated yet. Further
characterization of these regions would reveal regula-
tions of CRELD2 and ALG12 mRNA expression.
Using various deletion mutation constructs, we
showed that three suppressive sites in the CRELD2-
ALG12 gene pair play a crucial role in interfering with
Tg responsiveness. Interestingly, the deletion of all three
I III II
A
B
0 50 100 150 200 250 300
pGL3b -
+
Tg
Relative luciferase activity
ALG12
-
+ -361/+11
-
+ -361/+11 m4
-
+ -361/+11 m5
-
+ -361/+11 m6
-
+ -361/+11 m7
pGL3b -
+
0 5 10 15 20 25 30
Tg Relative luciferase activity
I III II
-209/+396
pGL3b -
+
-
+
0 5 10 15 20 25 30 35
Tg Relative luciferase activity
-209/+396 m1 -
+
-209/+396 m2 -
+
C
+11 -361 ALG12
-
+ -361/+11 m7 5’-ACCAATTGAGGCTCGCCACGAGAAGCCACCAATG-3’
-361/+11 m8 -
+
AgactaTGAGGCTCGCCACGAGAAGCCACCAATG
-361/+11 m9 -
+
ACCAATTGAGGCTCGCCACGAGAAGCCAgactaG
-209 -396 CRELD2
3’-TGGTTAACTCCGAGCGGTGCTCTTCGGTGGTTAC-5’
TctgatACTCCGAGCGGTGCTCTTCGGTGGTTAC
TGGTTAACTCCGAGCGGTGCTCTTCGGTctgatC
Figure 7 Characterization of the suppressive sites affecting the activity of the mouse CRELD2 and ALG12 promoters. Neuro2a cells were
transfected with the indicated CRELD2 or ALG12 reporter constructs. Twenty-four hours after transfection, the cells were incubated with or
without Tg (0.1 μM) for 10 h, and the luciferase activity was measured (A, B and C). Each deleted suppressive site in the CRELD2 and ALG12
promoters is shown as site I, II or III. The ERSE motif and two NF-Y binding sites in the mouse CRELD2 and ALG12 reporters are shown with a
box and underlines, respectively. The nucleotide sequence of the each mutated NF-Y binding site is shown with small letters (B and C). Control
and Tg-treated activities are shown as open and closed columns, respectively. Values represent means ± SD from 3 independent cultures and
are expressed relative to the basal activity of the pGL3-Basic vector.
Oh-hashi et al. BMC Genomics 2010, 11:664
http://www.biomedcentral.com/1471-2164/11/664
Page 9 of 13of these suppressive sites was required in order to
restore the responsiveness to Tg (Figure 2, 7 and 8).
These results imply that these suppressive sites are not
only important in maintaining basal promoter activity,
but that they synergistically counteract the ERSE-
mediated transcriptional activity (Figure 9). Among
these sites, the most proximal to the ALG12 promoter
contains a conserved response element that Ets-family
transcriptional factors recognize [21]. Ets transcription
factors consist of approximately 30 family members and
share a highly conserved DNA-binding domain. It has
been reported that these factors are involved in regulat-
ing a variety of biological processes including develop-
ment, differentiation and inflammation [21,22]. In the
site II, there are putative YY1- (GCCATC) [23] and
MAZ- (CCCCGCCCT) [24] binding sites judged from
some databases such as SwissRegulon (a database of
genome-wide annotations of regulatory sites), but the
precise roles remain to be determined. On the contrary,
B
A
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Figure 8 Characterization of the promoter activity of the full intergenic region of the mouse CRELD2-ALG12 gene pair. A) Neuro2a cells
were transfected with the indicated CRELD2 or ALG12 reporter constructs. Twenty-four hours after transfection, the cells were incubated with or
without Tg (0.1 μM) for 10 h, and the luciferase activity was measured. B) The expression vector for ATF6 or an empty vector (mock) was
co-transfected with each reporter construct into Neuro2a cells. Thirty-six hours after transfection, luciferase activity for each construct was
measured. Control and Tg- or ATF6-stimulated activities are shown as open and closed columns, respectively. Values represent means ± SD from
3 independent cultures and are expressed relative to the basal activity of the pGL3-Basic vector.
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Figure 9 Proposed mechanisms regulating promoter activities
in the intergenic region of CRELD2 and ALG12 gene pair. Under
ER stress conditions, ATF6 and NF-Y translocate into nucleus, form
complex and specifically bind the ERSE motif to induce CRELD2 and
ALG12 promoter activities. Three sites (I, II and III) in the intergenic
region identified in this study are important for their basal promoter
activities. However, factors binding to the site I, II and III could
antagonize the ERSE-mediated up-regulation of both promoter
activities cooperatively. According to the database of transcription
regulatory motifs, the site II contains putative YY1- and MAZ-
binding motifs and the site III contains an Ets family-binding motif,
respectively.
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Page 10 of 13we are unable to find any unique sequences in the sites
I. Further studies characterizing each of these suppres-
sive sites (site I, II, and III) are required in order to
understand the complex transcriptional regulation of the
CRELD2-ALG12 gene pair. Jones PL et al. reported that
murine manganese superoxide dismutase gene is regu-
lated through a complex intronic enhancer involving C/
EBP-b and NF-B [25]. Donati G et al. demonstrated
that ER stress triggers dynamic modification of chroma-
tin components and transcriptional factors under ER
stress [20]. Therefore, we should focus on other aspects
such as local chromatin remodeling and histone modifi-
cations (e.g., phosphorylation, acetylation and methyla-
tion of histones) within the CRELD2 and ALG12 genes
in addition to the 5’-flanking sequences in this inter-
genic region. Furthermore, other approaches should be
employed to elucidate the discrepancy between the
expression levels of both intrinsic mRNAs and the pro-
moter activities of their full intergenic region under ER
stress conditions.
Among the bidirectional gene pairs characterized in
mammalian cells, Surf1-Surf2 [6],R e q l 4 -Lrrc14 [26],
PDCD10-SERPINI1 [27] and Thox-DUOXA [28] gene
pairs seem to share their intergenic region equally
because mutations in the transcription factor binding
sites decline those promoter activities equally. In con-
trast, the transcriptional regulations of C2ORF34-PREPL
[5], Sarsm-Mrps12 [7] and HAND2-DEIN [29] are asym-
metric. According to the present study, the transcrip-
tional regulatory pattern of the mouse CRELD2-ALG12
gene pair belongs to the latter group. Analyses of these
bidirectional gene pair sharing a common intergenic
region have mostly consisted of characterization without
any stimuli. Recently, Zanotto E et al. reported that the
Sarsm-Mrps12 promoter activity is modulated by mito-
chondrial stresses, especially mitochondrial reactive oxy-
gen species, in a complex manner [30]. At this time,
however, the significance and relevance of many bidirec-
tional gene pairs under pathophysiological conditions
are not well understood.
The mammalian ALG12 gene is the ortholog of the
yeast gene that encodes the dolichyl-P-Man:Man7-
GlcNAc2-PP-dolichyl a6-mannosyltransferase, and its
mutation causes a congenital disorder affecting glycosy-
lation in the ER [14,31,32]. Clinically, a child suffering
from a point mutation in the ALG12 gene has been
reported to show severe symptoms such as psychomotor
retardation, hypotonia, growth retardation, dysmorphic
features and anoxia [31]. Sequential protein glycosyla-
tion in the ER is important in maintaining the quality
control of glycoproteins through folding and ER-asso-
ciated protein degradation. Moreover, its defects could
also interfere with the intracellular trafficking and secre-
tion of glycoproteins. Therefore, suitable regulation of
the ALG12 gene should be required in order to maintain
ER homeostasis.
As the CRELD proteins have multiple EGF-like domains,
they are considered to be cell adhesion molecules [33-35].
It has been reported that missense mutations in the
CRELD1 gene increases an individual’s susceptibility to
atrioventricular septal defects [33], but the physiological
roles of these family members remain poorly understood.
In contrast to CRELD1, CRELD2 lacks a transmembrane
domain in the C-terminal region. Ortiz et al.r e p o r t e dt h a t
the overexpression of CRELD2 impairs the membrane
transport of acetylcholine receptor a4/b2i nXenopus lae-
vis oocytes [36]. We recently demonstrated that the
CRELD2 gene is one of the downstream targets of ATF6
a n dt h a ti t sp r o d u c ti sp r e d o m i n a n t l yl o c a l i z e di nt h e
ER-Golgi apparatus [8]. Interestingly, the mouse model for
multiple epiphyseal dysplasia, which specifically expresses
a mutation in matrilin-3, was reported to induce CRELD2
mRNA expression and other ER-stress inducible genes as
the symptoms progressed [37]. According to these reports,
CRELD2 seems to be involved in the folding, processing
and transport of some proteins under pathophysiological
conditions, though the precise role of CRELD2 remains to
be determined. Furthermore, we believe that the sharing
of the ERSE motif in the CRELD2-ALG12 gene pair may
be advantageous in regulating ER homeostasis under var-
ious ER-stress conditions, even though it is unlikely that
the CRELD2 and ALG12 proteins function by directly
interacting with each other.
Conclusion
In this study, we first demonstrate that both the
CRELD2 and ALG12 genes, which form a bidirectional
gene pair, are potent ER stress-inducible genes. Our pre-
sent results indicate that the CRELD2-ALG12 gene pair
could be asymmetrically regulated by multiple transcrip-
tional factors in addition to ATF6. Because the
CRELD2-ALG12 gene pair contains an evolutionally
conserved ERSE motif, the cooperative induction of
these genes may play important roles in confronting ER
stresses and in appropriately regulating ER homeostasis
and cell fates, together with other ER stress-inducible
genes (e.g., GRP78 and GADD153). Therefore, further
characterization of the CRELD2-ALG12 gene pair may
provide new insights into the complex transcriptional
regulation of ER stress-inducible genes as well as
into the onset and progression of various ER stress-
associated diseases.
Methods
Cell culture and treatment
Neuro2a cells were maintained in Dulbecco’sM o d i f i e d
Eagles minimum essential Medium containing 8% fetal
bovine serum. Transfection of each construct used in
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Page 11 of 13this study was performed using Lipofectamine-Plus
reagent (Invitrogen) according to the manufacturer’s
instructions. For stimulation, Neuro2a cells were treated
with Tg (0.1 μM), Tm (5 μg/ml), BFA (5 μg/ml) or
serum-free medium (SF) for the indicated time.
Construction of plasmids
For preparation of reporter constructs for the mouse
CRELD2 and ALG12 promoters, genomic DNA from Neu-
ro2a cells was extracted, and the mouse CRELD2 and
ALG12 promoters were amplified by polymerase chain
reaction (PCR) and cloned into the pGL3-Basic vector
(Promega). To evaluate the promoter activity of the inter-
genic region of the mouse CRELD2 and ALG12 genes, the
position of the putative transcriptional start site of mouse
CRELD2 or ALG12 is defined as -362 and +1, respectively.
The promoter region was defined using a database of the
NIH full-length cDNA project and RIKEN functional
annotation of a full-length mouse cDNA collection (FAN-
TOM). To characterize the enhancer activity of the partial
intergenic region containing ERSE (-343 ~ -212), it was
inserted into the pGL3-Promoter vector (Promega). We
also constructed various other bidirectional reporter con-
struct carrying point and deletion mutations. Mouse ATF6
was amplified by PCR using cDNA from Neuro2a cells
and cloned into the pFlag-CMV vector.
Reverse transcription polymerase chain reaction (RT-PCR)
To estimate the expression level of each gene by RT-PCR,
total RNA was extracted from cells lysed with Trizol and
converted to cDNA by reverse transcription using random
ninemers to prime superscript III RNase
- reverse tran-
scriptase (RT) (Invitrogen) as previously described [8].
Specific cDNAs were mixed and amplified with a PCR
reaction mixture (Taq PCR kit, Takara). The RT-PCR pri-
mers used in this study were as follows: CRELD2 sense
primer 5’-ACTGAAGAAGGAGCACCCCAAC-3’,
CRELD2 antisense primer 5’-GCACACTCATCCACATC-
CACACA-3’, ALG12 sense primer 5’-GTGATTTCTG-
GACTCTGGAC-3’, ALG12 antisense primer 5’-GGGGT
ATGAAGAGAAGGCTGCA-3’, GADD153 sense primer
5’-GAATAACAGCCGGAACCTGA-3’, GADD153 anti-
sense primer 5’-GGACGCAGGGTCAAGAGTAG-3’,
GRP78 sense primer 5’-ACCAATGACCAAAACCGCCT-
3’, GRP78 antisense primer 5’-GAGTTTGCTGATAAT
TGGCTGAAC-3’, GAPDH sense primer 5’-ACCACAG
TCCATGCCATCAC-3’, GAPDH antisense primer 5’-TC
CACCACCCTGTTGCTGTA-3’. The typical reaction
cycle conditions were 30 sec at 96°C, 30 sec at 60°C and
30 sec at 72°C. The results represent 18 ~ 33 cycles of
amplification, after which cDNAs were separated by elec-
trophoresis on 2.0% agarose gels and visualized using ethi-
dium bromide. Experiments were repeated to confirm
reproducibility.
GeneChip analysis
After Neuro2a cells were incubated in the absence or
presence of Tg for the indicated time, total RNA was
extracted as described in the above methods. After mea-
suring the quantity and quality of the RNA, biotin-
labeled cRNAs were generated from 5 μg of each total
RNA using a GeneChip® One-Cycle Target Labeling and
Control Reagents package (Affymetrix) according to the
manufacturer’s protocol. Afterwards, 15 μgo ft h ep u r i -
fied cRNAs were mixed with 3 nM Control Oligo B2,
and the hybridization cocktail was denatured at 99°C for
5 min in a heat block, followed by incubation at 45°C
for 5 min, and centrifugation for 5 min in order to
remove any insoluble material. Hybridization to a
mouse DNA array (GeneChip® Mouse Genome 430 2.0
Array) was carried out at 45°C for 16 h using a hybridi-
zation oven 640 (Affymetrix). After hybridization, the
arrays were washed and stained with the GeneChip®
Hybridization Wash and Stain Kit (Affymetrix) using the
GeneChip® Fluidics Station 450 (Affymetrix) according
to the manufacturer’s protocol. The signal intensities
were quantified using a GeneArray Scanner 3000 (Affy-
metrix), and the raw data obtained were converted into
MAS (Microarray Suite) files using the GeneChip® Oper-
ating Software (GCOS). After normalization, the identifi-
cation of the temporal expression patterns of genes was
performed using the Spotfire® DecisionSite. In this ana-
lysis, the mean signal intensity of gene expression in
each group included in the study (three samples/group)
was used. As a selection criteria to present only the
most relevant genes, a cutoff of a 2.0-fold increased/
decreased expression and a p < 0.01 were arbitrarily
chosen.
Reporter gene assay
Reporter constructs and the pRL-TK vector, an internal
control, were transfected into Neuro2a cells in a 48-well
plate. Twenty-four hours after transfection, the cells
were treated with Tg (0.1 μM) or vehicle for 10 ~ 12 h.
To determine the effects of ATF6 on reporter activity,
the ATF6 expression vector or empty vector (mock)
was co-transfected with the reporter construct into the
cells and cultured for 36 h. After incubation under each
condition, the cells were lysed and the luciferase activity
in each lysate was measured using a Dual-Luciferase
assay system (Promega). Reporter activity in each lysate
was normalized to the co-transfected Renilla luciferase
activity, and the results are shown as relative luciferase
activity.
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